| 14/09/2014 | ||||
 2:00 pm - 4:00 pm | Registration Ghan Foyer | |||
| 4:00 pm - 4:10 pm | Transfers Outside Ghan Foyer | |||
| 4:30 pm - 7:30 pm | Welcome Reception - Return Transfers Provided Telegraph Station | |||
| 15/09/2014 | ||||
| 7:30 am - 8:30 am | Registration Ghan Foyer | |||
| 8:30 am - 10:40 am | Opening Ceremony and Plenary A MacDonnel Room A and B Chairperson: Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Chairperson: Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 8:30 am - 8:40 am | Welcome To Country MacDonnel Room A and B | |||
| 8:40 am - 9:00 am | Introduction to the Conference MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia | |||
| 9:00 am - 9:25 am | Opening Keynote Address: First Peoples of Australia and Viral Hepatitis - Our Story MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia | |||
| 9:25 am - 9:50 am | Keynote Address: Viral Hepatitis Among the World's Indigenous Peoples MacDonnel Room A and B Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 9:50 am - 10:15 am | Management of Chronic Hepatitis B and C in Indigenous Populations living in Remote Areas: The Alaska Native Hepatitis Program Experience MacDonnel Room A and B Dr Brian McMahon, Clinical and Research Director of the Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, USA | |||
| 10:15 am - 10:40 am | Viral Hepatitis in The First Nations Peoples of North America MacDonnel Room A and B Dr John Ward, Director of the Division of Viral Hepatitis , Centers for Disease Control and Prevention (CDC), USA | |||
| 10:40 am - 11:10 am | Morning Tea Ghan Foyer | |||
| 11:10 am - 12:30 pm | Plenary B MacDonnel Room A and B Chairperson: Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Chairperson: Dr Brian McMahon, Clinical and Research Director of the Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, USA | |||
| 11:10 am - 11:30 am | Hepatitis B and D in Brazilian Amazon Region Indigenous Populations – Prevalence, Clinical and Molecular Aspects MacDonnel Room A and B Wornei Braga, Md/PhD. Medical Researcher, Tropical Medicine Foundation of Amazonas, Brazil | |||
| 11:30 am - 12:10 pm | Viral Hepatitis, Health and Perspective of Indigenous People of Brazil (with translation) MacDonnel Room A and B Ana Salestino (Nara), Technical Nurse, Indigenous Health Team, Australia | |||
| 12:10 pm - 12:30 pm | Strategies of the Brazilian Government to Reach the Indigenous People and Provide Diagnosis, Prevention and Care No location Marcelo Naveira, Project Manager at Fiotec and National Coordinator , Viral Hepatitis for the Ministry of Health Brazil | |||
| 12:30 pm - 1:30 pm | Lunch Ghan Foyer | |||
| 1:30 pm - 2:45 pm | Proffered Paper Session A: Hepatitis B - Epidemiology, Audit and Biology MacDonnel Room A and B Chairperson: Henrik Krarup, Head of Section of Molecular Diagnostics , Aalborg University Hospital, Denmark Chairperson: Donna AhChee | Proferred Paper Session B: Hepatitis C - Yarning & Living with Hepatitis C Ellery Room A and D Chairperson: Bonny Briggs, Aboriginal Health and Medical Research Council, Australia Chairperson: Jessica Leston, HIV/STD/Hepatitis Clinical Programs Manager, Northwest Portland Area Indian Health Board, USA | ||
| 1.30pm - 1.45pm The outcome of a Hepatitis B clinical audit at the Central Australian Aboriginal Congress Aboriginal Corporation MacDonnel Room A and B John Boffa, Chief Medical Officer Public Health , Central Australian Aboriginal Congress , Australia Warwick Beever, Sexual Health Program Coordinator , Central Australian Aboriginal Congress, Australia | 1.30pm - 1.45pm Deadly Liver Mob Project~ Yarning up hepatitis C Ellery Room A and D Kerri-Anne Smith, Aboriginal Hep C Health Promotion officer, Australia David Webb, Aboriginal Sexual Health Promotion Officer, Nepean Blue Mountains local Health Districts, Australia | ||
| 1.45pm - 2.00pm The beachcomber trail of HBV-C subgenotypes along the route followed by the first wave of Homo sapiens out of Africa MacDonnel Room A and B Lilly Yuen, Senior Medical Scientist , Research and Molecular Development Department at the Victorian Infectious Diseases Reference Laboratory, Australia | 1.45pm - 2.00pm Client experiences of undertaking HCV treatment through an Aboriginal Community Controlled Health Service: Insights from a qualitative evaluation Ellery Room A and D Julie Mooney-Somers, Senior lecture, Centre for Values, Ethics and the Law in Medicine, University of Sydney, Australia Belinda Hammond | ||
| 2.00pm - 2.15pm Phylogeography of Hepatitis B Virus, sub-genotype C4 in Indigenous Australians. MacDonnel Room A and B Margaret Littlejohn, Molecular Virologist and Senior Medical Scientist , Molecular Research and Development laboratory at VIDRL, Australia | 2.00pm - 2.15pm Yarning about Hep C; Aboriginal Victorians telling our stories about living with Hep C Ellery Room A and D Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia Andrew Bamblett, Australia | ||
| 2:15 pm - 2:45 pm | Afternoon Tea Ghan Foyer | |||
| 2:45 pm - 3:30 pm | Plenary C MacDonnel Room A and B Chairperson: Prof. Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory, CEVHAP, Australia | |||
| 2:45 pm - 3:00 pm | “Only Your Blood Can Tell the True Story”: A New iPad-based Educational Resource on HBV MacDonnel Room A and B Dr Jane Davies, Clinical Fellow , Royal Darwin Hospital, Australia Sarah Bukilatjpi, Aboriginal Health Worker, Ngalkanbuy clinic in East Arnhem Land, Australia | |||
| 3:00 pm - 3:30 pm | Viral Hepatitis in the Circumpolar Region of Russia MacDonnel Room A and B Dr Vladimir Chulanov, Head of Reference Centre for Viral Hepatitis , Central Research Institute of Epidemiology, Reference Centre for Viral Hepatitis, Moscow, Russia | |||
| 3:30 pm - 3:50 pm | Transition between rooms No location | |||
| 3:50 pm - 4:50 pm | Proffered Paper Session C: Hepatitis B - Surveillance, Education and Communities MacDonnel Room A and B Chairperson: Dr Vladimir Chulanov, Head of Reference Centre for Viral Hepatitis , Central Research Institute of Epidemiology, Reference Centre for Viral Hepatitis, Moscow, Russia Chairperson: Tony Coburn, Queensland Aboriginal & Islander Health Council, Australia | Proffered Paper Session D: Hepatitis C - Assessment & Analysis Ellery Room A and D Chairperson: Jennifer MacLachlan, Epidemiologist, Victorian Infectious Diseases Reference Laboratory, Australia Chairperson: Dr Brian McMahon, Clinical and Research Director of the Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, USA | ||
| 3.50pm - 4.05pm Yarning about hep B: an awareness and educational program for Victorian Aboriginal communities MacDonnel Room A and B Garry Irving, Programs and Operations Manager , Hepatitis Victoria, Australia Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia | 3.50pm - 4.05pm Prevalence and incidence of chronic hepatitis C among indigenous people who inject drugs in Melbourne, Australia Ellery Room A and D Mark Stoove, Head of the HIV Research and Justice Health Research Programs, Burnet Institute in Melbourne, Australia | ||
| 4.05pm - 4.20pm The establishment of a culturally sensitive hepatitis B surveillance program in an semiurban indigenous community inYarrabah Far North Queensland MacDonnel Room A and B Rhondda Lewis, GP, Hep b program in Yarrabah, Australia Milton Mossman, Indigenous Sexual Health Worker, Gurriny Yealamucka Health Service, Australia Katrina Connolly, Sexual Health worker , Gurriny Yealamucka Health Service, Australia | 4.05pm - 4.20pm A descriptive analysis of routine HCV testing data from four Aboriginal Community Controlled Health services: testing, positivity, follow up and context of testing Ellery Room A and D Mary Ellen Harrod, Clinical Project Leader/Research Fellow , Kirby Institute, Australia | ||
| 4.20pm - 4.35pm A New Zealand Community-Based Model for Follow-up of People with Chronic Hepatitis B: Does it make a difference? MacDonnel Room A and B John Hornell, Chief Executive Officer, Hepatitis Foundation of New Zealand | 4.20pm - 4.35pm Assessing the knowledge, care and treatment of Aboriginal people living with hepatitis C in NSW Ellery Room A and D Loren Brener, Senior Research Fellow , Centre fof Social Research in Health, UNSW, Australia | ||
| 4.35pm - 4.50pm “It really is in a pretty competitive space to get a profile”: Facilitators and barriers to providing hepatitis B clinical care to Aboriginal people in South Australia MacDonnel Room A and B Dr Anna Olsen, NHMRC post-doctoral fellow , Kirby Institute, UNSW, Australia | 4.35pm - 4.50pm Assessing the Knowledge, Care and Treatment of Aboriginal People Living with Hepatitis C in New South Wales: Information, Stigma and Resilience Ellery Room A and D Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | ||
| 4:50 pm - 5:00 pm | Transition between rooms No location | |||
| 5:00 pm - 5:30 pm | Plenary D MacDonnel Room A and B Chairperson: Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Chairperson: Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 5:00 pm - 5:25 pm | Introduction to Consensus Statement MacDonnel Room A and B Charles Gore, President, World Hepatitis Alliance, Geneva, Switzerland | |||
| 5:00 pm - 5:25 pm | End of day one Remarks MacDonnel Room A and B | |||
| 5:30 pm - 5:30 pm | End of Conference MacDonnel Room A and B | |||
| 6:00 pm - 10:00 pm | Conference Dinner – Return Transfers Provided from Convention Centre to Desert Park Desert Park | |||
| 16/09/2014 | ||||
| 7:30 am - 9:00 am | Registration Ghan Foyer | |||
| 9:00 am - 11:00 am | Plenary E MacDonnel Room A and B Chairperson: Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Chairperson: Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 9:00 am - 9:20 am | Introduction MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia | |||
| 9:20 am - 9:45 am | Spring Breakup: Indigenous Women in Canada and Hep C MacDonnel Room A and B Alexandra King, BC Women’s Hospital and Health Clinic, Canada | |||
| 9:45 am - 10:10 am | Alcohol Intake and Liver Biochemistry in Inuit with Frequent Hepatitis B Virus Infection: A Population-based Comparative Epidemiological Survey in Grenland and Denmark MacDonnel Room A and B Karstan Rex, Department of Internal Medicine, Queen Ingrid’s Hospital, Greenland | |||
| 10:10 am - 10:35 am | Increasing Primary Care Capacity for Hepatitis C Screening, Care and Treatment for American Indian/Alaska Native People MacDonnel C Jessica Leston, HIV/STD/Hepatitis Clinical Programs Manager, Northwest Portland Area Indian Health Board, USA | |||
| 10:35 am - 11:00 am | Hepatitis among Indigenous People of Taiwan MacDonnel Room A and B Dr Hans Hsienhong Lin, Attending Physician, Department of Hepato-Gastroenterology, Taipei Tzu Chi Hospital, Taiwan | |||
| 11:00 am - 11:30 am | Morning Tea Ghan Foyer | |||
| 11:30 am - 12:30 pm | Proferred Paper Session E: Hepatitis B - Vaccines and Therapy MacDonnel Room A and B Chairperson: Dr Dieter Glebe, Head, National Reference Centre for Hepatitis B and D Viruses, Institute of Medical Virology, Germany Chairperson: Helen Tyrell, CEO, Hepatitis Australia | Proferred Paper Session F: Hepatitis C - Leadership, Support and Education Ellery Room A and D Chairperson: Brett Mooney Chairperson: Alexandra King, BC Women’s Hospital and Health Clinic, Canada | ||
| 11.30am - 11.45am Use of Antiviral therapy in Pregnant Women with Hepatitis B in the Top End of the Northern Territory, Australia MacDonnel Room A and B Catherine Marshall, Infectious Diseases Physician , Royal Darwin Hospital, Australia | 11.30am - 11.45am The Connection’s “Young, Strong & Smart” Leadership Program- Working Together as Peers to Educate on Viral Hepatitis within the Aboriginal Community. Ellery Room A and D Aimee Capper, Aboriginal Peer Support Worker , The Connection, Australia | ||
| 11.45am - 12.00pm Can the current Hepatitis B vaccine mark the end of the Australia antigen in the Northern Territory of Australia or is the Territory just different? MacDonnel Room A and B Dr Jane Davies, Clinical Fellow , Royal Darwin Hospital, Australia | 11.45am - 12.00pm Aboriginal Hepatitis C Peer Education in Inner West Sydney Ellery Room A and D Damian House, Hepatitis Peer Educator/Aboriginal HEO , Sydney Local Health District, Australia | ||
| 12.00pm - 12.15pm Mapping the HBsAg phenotype to identify vaccine escape MacDonnel Room A and B Dr Renae Walsh, Senior Medical Scientist , VIDRL, Australia | 12.00pm - 12.15pm Resources to Support Hepatitis C Decision-Making in Canadian Aboriginal Populations MacDonnel Room A and B Sandi Mitchell | ||
| 12.15pm - 12.30pm Promoting Art and Story for Indigenous Health MacDonnel Room A and B Nicky Guivarra | 12.15pm - 12.30pm Living with Hepatitis C – is there hope? Ellery Room A and D Leona Quewezance, Program Director, All Nations Hope Network, Regina, Sask, Canada | ||
| 12:30 pm - 2:00 pm | Lunch Ghan Foyer | |||
| 1:00 pm - 2:00 pm | Indigenous Caucus - Discussion and Confirmation of Consensus Statement Ellery Room A and D Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 2:00 pm - 3:20 pm | Plenary F MacDonnel Room A and B Chairperson: Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Chairperson: Marcelo Naveira, Project Manager at Fiotec and National Coordinator , Viral Hepatitis for the Ministry of Health Brazil | |||
| 2:00 pm - 2:25 pm | Viral Hepatitis: Biogeography and Pathogenesis MacDonnel Room A and B Prof. Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory, CEVHAP, Australia | |||
| 2:25 pm - 2:55 pm | Hepatitis B Genotypes in Greenland and Denmark – Importance? MacDonnel Room A and B Henrik Krarup, Head of Section of Molecular Diagnostics , Aalborg University Hospital, Denmark | |||
| 2:55 pm - 3:20 pm | Relevance of Hepatitis B Virus Genotypes in HBV/HIV Coinfected Patients from Sudan MacDonnel Room A and B Dr Dieter Glebe, Head, National Reference Centre for Hepatitis B and D Viruses, Institute of Medical Virology, Germany | |||
| 3:20 pm - 3:45 pm | Afternoon Tea Ghan Foyer | |||
| 3:45 pm - 5:15 pm | Plenary G: Report Back on Consensus Statement and Closing Plenary MacDonnel Room A and B Chairperson: Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Chairperson: Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 3:45 pm - 4:15 pm | Epidemiology of Hepatitis in Peru and Loreto Region (with translation) MacDonnel Room A and B Dra. Gladys Ramirez Prada, Medical Epidemiologist, Member of Advisory Committee of ACLCH, Peru | |||
| 4:15 pm - 4:45 pm | Tomasa’s Journey and Kandozi-Shapra Peoples in their Struggle Against Hepatitis B: A Story of Love and Power from Peru MacDonnel Room A and B Pillar Collantes, Vice-President , Citizen's Association for the Struggle Against Hepatitis, Peru | |||
| 4:45 pm - 5:00 pm | Report Back to the Conference on the Results of the Indigenous Forum MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 5:00 pm - 5:15 pm | Closing Address and Conference Handover MacDonnel Room A and B | |||
| 5:15 pm - 6:45 pm | End of Conference - Network Reception Ghan Foyer | |||
| 17/09/2014 | ||||
| 10:30 am - 1:45 pm | Registration Ghan Foyer | |||
| 1:45 pm - 4:00 pm | Opening Ceremony Plenary MacDonnel Room A and B Chairperson: Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Chairperson: Dr Josh Davis, Diseases physician , John Hunter Hopsital, Australia Chairperson: Annie Madden, Executive Officer , Australian Injecting & Illicit Drug Users League (AIVL), Australia | |||
| 1:50 pm - 1:55 pm | Welcome To Country MacDonnel Room A and B | |||
| 1:55 pm - 2:00 pm | Dignitary Presentation MacDonnel Room A and B | |||
| 2:00 pm - 2:05 pm | Dignitary Presentation MacDonnel Room A and B | |||
| 2:05 pm - 2:10 pm | Introduction by Representative of the 2014 Viral Hepatitis Conference Collaborating Organisations MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia | |||
| 2:10 pm - 2:20 pm | Auckland Statement - Report Card MacDonnel Room A and B Helen Tyrell, CEO, Hepatitis Australia John Hornell, Chief Executive Officer, Hepatitis Foundation of New Zealand | |||
| 2:20 pm - 2:30 pm | The importance of the principle of meaningful affected community engagement and the practical implications for a partnership approach MacDonnel Room A and B Annie Madden, Executive Officer , Australian Injecting & Illicit Drug Users League (AIVL), Australia Yvonne Drazic, Australia | |||
| 2:30 pm - 2:50 pm | Overview of the World Indigenous People’s Conference on Viral Hepatitis and Consensus Statement MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Professor Chris Cunningham, Hepatitis Foundation of NZ, New Zealand | |||
| 2:50 pm - 3:20 pm | From Data to Policy: Hepatitis B and Hepatitis C Prevention Policies in the United States MacDonnel Room A and B Dr John Ward, Director of the Division of Viral Hepatitis , Centers for Disease Control and Prevention (CDC), USA | |||
| 3:20 pm - 3:40 pm | State of the Art – Interferon-free therapy for hepatitis C MacDonnel Room A and B Alex Thompson, Research Fellow , University of Melbourne (St Vincent's Hospital Melbourne), Australia | |||
| 3:40 pm - 4:00 pm | Addressing Hepatitis B through Community Action MacDonnel Room A and B Alison Coelho, Manager of Multicultural Health and Support Service, Center for Culture, Ethnicity and Health, Melbourne, Australia | |||
| 4:00 pm - 4:30 pm | Afternoon Tea MacDonnel C | |||
| ||||
| 4:30 pm - 6:00 pm | Cross-Track Symposium -Viral Hepatitis and Substance Use MacDonnel Room A and B Chairperson: Dr Angella Duvnjak, Team Leader for the Hepatitis and other BBVs program , Australian Injecting and Illicit Drug Users League (AIVL), Australia Chairperson: Professor Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia | Cross-Track Symposium - The challenges and possible solutions for addressing hepatitis B across key priority populations Ellery Room A and D Chairperson: Bob Batey | ||
| 4.30pm - 4.45pm Treatment for Hepatitis C virus infection among people who inject drugs in the opioid substitution setting: The ETHOS Study MacDonnel Room A and B Michelle Micallef, Clinical Project Coordinator for the Healthy Liver Campaign , Kirby Institute, Australia | 4.30pm - 4.50pm Epidemiology of chronic hepatitis B in key priority populations - similarities and diff erences Ellery Room A and D Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia | ||
| 4.45pm - 5.00pm Evaluation of Two Community-Controlled Peer Support Programs for Assessment and Treatment of Hepatitis C Virus Infection in Opioid Substitution Treatment Clinics: The Ethos Study, Australia MacDonnel Room A and B Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | 4.50pm - 5.40pm Panel Session - Commonalities and differences between the issues faced by Aboriginal and Torres Strait Islander peoples and people from culturally and linguistically diverse backgrounds Ellery Room A and D Dr David Scrimgeour, Public Health Medical Officer, Aboriginal Health Council of SA, Australia Professor Gracelyn Smallwood, James Cook University, Townsville, Australia Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Jacqui Richmond, Research Fellow , Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis, Australia Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Melbourne, Australia Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia | ||
| 5.00pm - 5.15pm Liverlife: A Healthy Liver Campaign among People Who Inject Drugs in the Drug and Alcohol Setting MacDonnel Room A and B Michelle Micallef, Clinical Project Coordinator for the Healthy Liver Campaign , Kirby Institute, Australia | |||
| 5.15pm - 5.30pm Liver Mates: Why must the affected community be supported to lead on the development and delivery of hepatitis C treatment and healthy liver interventions? MacDonnel Room A and B Nicky Bath, CEO, NSW South Wales Users and AIDS Association, Australia | 5.40pm - 6.00pm Recommendations for action for addressing chronic hepatitis B across key priority populations Ellery Room A and D Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Dr David Scrimgeour, Public Health Medical Officer, Aboriginal Health Council of SA, Australia Professor Gracelyn Smallwood, James Cook University, Townsville, Australia Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Jacqui Richmond, Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis, Australia Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Melbourne, Australia | ||
| 5.30pm - 6.00pm Panel Discussion MacDonnel Room A and B Dr Angella Duvnjak, Team Leader for the Hepatitis and other BBVs program , Australian Injecting and Illicit Drug Users League (AIVL), Australia Professor Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia Michelle Micallef, Clinical Project Coordinator for the Healthy Liver Campaign , Kirby Institute, Australia Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia Nicky Bath, CEO, NSW South Wales Users and AIDS Association, Australia Conjoint Associate P Adrian Dunlop, University of Newcastle, Australia Hope Everingham, Peer Support Worker , NSW Users and AIDS Association (NUAA), Australia | |||
| 6:00 pm - 7:30 pm | Welcome Reception & Poster Viewing Evening, Transport will be provided back to hotels MacDonnel C | |||
| 18/09/2014 | ||||
| ||||
| 7:30 am - 8:30 am | Registration Ghan Foyer | |||
| 8:30 am - 9:30 am | Conference Plenary 2: Central issues in Global access for Hepatitis C treatment MacDonnel Room A and B Chairperson: Professor Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia Chairperson: Helen Tyrell, CEO, Hepatitis Australia | |||
| 8:30 am - 9:00 am | Brave New World for Hepatitis C - How do we ensure resource limited countries aren’t left behind MacDonnel Room A and B Professor Margaret Hellard, Head of the Centre for Population Health and Head of Hepatitis Services Infectious Diseases Unit, , Burnet Institute in Melbourne and The Alfred Hospital, Melbourne, Australia | |||
| 9:00 am - 9:30 am | Advocating for access to HCV treatment: Community experiences from Asia MacDonnel Room A and B Giten Khwairakpam, Community and Policy Project Manager, amfAR’s TREAT Asia program, Bangkok, Thailand | |||
| 9:30 am - 10:20 am | Morning Tea in Exhibition and Poster Area MacDonnel C | |||
| 9:40 am - 10:10 am | Launch of Kirby and CSRH Stats Ellery Room A and D | |||
| 10:20 am - 11:50 am | Profferred Paper Session: Epi, PH & Prevention - Trends and Trajectories MacDonnel Room A and B Chairperson: Sushena Krishnaswamy, Alice Springs Hospital, Australia Chairperson: Dr Nicole Allard, General Practitioner , Joslin Clinic, Cohealth in West Footscray, Melbourne, Australia | Profferred Paper Session: Clinical Care - HBV Ellery Room A and D Chairperson: Dr Jill Benson, GP, Kakarrara Wilurrara Health Alliance, Australia Chairperson: Saliya Hewagama, Infectious Diseases Physician, Alice Springs Hospital, Australia | Proffered Paper Session: Community & Social Research - Preventing Viral Hepatitis Ellery B Chairperson: Charles Henderson, NZ Needle Exchange Program, New Zealand | Proffered Paper Session: Community & Social Research - Engaging Community Ellery C Chairperson: Giten Khwairakpam, Community and Policy Project Manager, amfAR’s TREAT Asia program, Bangkok, Thailand Chairperson: Helen Tyrell, CEO, Hepatitis Australia |
| 10.20am - 10.35am Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012 MacDonnel Room A and B Jason Grebely, Epidemiologist and Senior Lecturer in the Viral Hepatitis , Kirby Institute, UNSW, Australia | 10.20am - 10.35am The role of financial incentives in developing hepatitis B immunity following accelerated vaccination among people who inject drugs in Sydney, Australia: randomised controlled trial MacDonnel Room A and B Carolyn Day, Hepatitis Nurse, Discipline of Addiction Medicine, Central Clinical School, Australia | 10.20am - 10.35am Everyday objects and injecting: Why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment? Ellery B Associate Professor Suzanne Fraser, Australian Research Council Future Fellow and leader, Social Studies of Addiction Concepts Research Program at the National Drug Research Institute,Melbourne, Australia | |
| 10.35am - 10.50am Opioid substitution treatment protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study MacDonnel Room A and B Bethany White, Associate Lecture , Discipline of Addiction Medicine, University of Sydney, Australia | 10.35am 10.50am Treating Immune-tolerant HBV: Factors Associated with Significant Decline in HBeAg and HBsAg Levels Ellery Room A and D Gillian Rosenberg, Post-Doctoral Medical Scientist , ictorian Infections Diseases Reference Laboratory, Melbourne, Australia | 10.35am - 10.50am Negotiating risk, navigating relationship: accounts of needle-syringe sharing within romantic partnerships Ellery B Jake Rance, Research Associate, Centre for Social Research, Australia | 10.20am - 10.38am So Heppy Together: Perceptions of peers and its impact on south-south hepatitis C capacity building collaborations Ellery C Dr Angella Duvnjak, Team Leader for the Hepatitis and other BBVs program , Australian Injecting and Illicit Drug Users League (AIVL), Australia |
| 10.50am - 11.05am Low rates of re-infection long-term following recently acquired HCV in the Australian Trial of Acute Hepatitis C: the ATAHC Recall study MacDonnel Room A and B Joseph Doyle, NHMRC Postgraduate Scholar , Burnet Institute in Melbourne, Australia | 10.50am - 11.05am Use of Antiviral therapy in Pregnant Women with Hepatitis B in the Top End of the Northern Territory Ellery Room A and D Catherine Marshall, Infectious Diseases Physician , Royal Darwin Hospital, Australia | 10.50am - 11.00am Innovation in Hepatitis C Prevention: A Trial of Symbiotic and Pleasure-Based Messages with NSP Staff and Clients Ellery B Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | 10.38am - 10.56am Learning by doing- CALD youth as hepatitis B community educators Ellery C Monica Robotin, Chief Investigator of the B Positive program, Australia |
| 11.05am - 11.13am Trends in chronic hepatitis B diagnosis In Australia, 2009-2013 MacDonnel Room A and B Jennifer MacLachlan, Epidemiologist, Victorian Infectious Diseases Reference Laboratory, Australia | 11.05am - 11.20am Improving quality of care for people living with hepatitis B in primary care: preliminary data from the Integrated Hepatitis B Service. Ellery Room A and D Tracey Cabrie, Hepatitis B Clinical Nurse Consultant , Victorian Infectious Diseases Service, Royal Melbourne Hospital, Australia | 11.00am - 11.15am Peer Education the forgotten tool for fighting viral hepatitis Ellery B Yvonne Samuel, Treatment and Care Coordinator, NSW Users and AIDS Association (NUAA), Australia | 10.56am - 11.14am Hepatitis workforce development: A decade of learning The ABCs Ellery C Lana Pocock, ABC Co-ordinator, Hepatitis Queensland, Australia |
| 11.13am - 11.21am Trends in Relative Survival of Patients Diagnosed With Hepatocellular Arcinoma: A Population-Based Cohort Study MacDonnel Room A and B Hla-Hla (Rosie) Thein, Canada | 11.20am - 11.35am Management of Hepatitis B during pregnancy at Geelong Hospital: a retrospective review Ellery Room A and D Sarah Beynon, Deakin University Medical Graduate, Geelong Hospital, Australia | 11.15am - 11.30am Building on Shaky Ground - a Peer Educator and Peer Leader Program in the ACT Ellery B Sione Crawford, Manager, CAHMA, Australia Peter Parkes, Peer Education Officer , CAHMA, Australia | 11.14am - 11.32am Improving chlamydia and hepatitis C awareness through a sexual and reproductive health education program for Aboriginal and Torres Strait Islander students in Victorian secondary schools Ellery C Bradley Whitton, Sexual Health Nurse , Melbourne Sexual Health Centre, Australia |
| 11.21am - 11.36am Time to Hepatocellular Carcinoma after Notification of Hepatitis B or C Infection: A Population-Based Cohort Study, 1992–2007 MacDonnel Room A and B Maryam Alavi, Epidemiologist and a Research Associate, Kirby Institute, Australia | 11.35am - 11.50am Discussion Ellery Room A and D | 11.30am - 11.40am Acquiring Hepatitis C in Prison: A Qualitative Study of the HITSP Cohort Ellery B Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | 11.32am - 11.50am Discussion Ellery C |
| 11.36am - 11.50am Discussion MacDonnel Room A and B | 11.40am - 11.50am Discussion Ellery B | ||
| 11:50 am - 12:50 pm | Lunch in Exhibition and Poster Area MacDonnel C | |||
| 12:10 pm - 12:40 pm | Research Consultation: Hepatitis C and couples who inject drugs Ellery B | |||
| 12:50 pm - 1:50 pm | Conference Plenary 3: Hep B in the past and future MacDonnel Room A and B Chairperson: Bob Batey Chairperson: Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia | |||
| 12:50 pm - 1:20 pm | Of bats and men: species specificity of hepadnaviral infection MacDonnel Room A and B Dr Dieter Glebe, Head, National Reference Centre for Hepatitis B and D Viruses, Institute of Medical Virology, Germany | |||
| 1:20 pm - 1:50 pm | HBV Reactivation: Playing with fire MacDonnel Room A and B Professor Maggie Bassendine, Clinician Scientist, Visiting Professor at Imperial College, London and Emeritus Professor at Newcastle University, UK | |||
| 1:50 pm - 2:00 pm | Movement to Concurrent Sessions No location | |||
| 2:00 pm - 3:30 pm | Cross-Track Symposium -Human Rights, The Law and Discrimination MacDonnel Room A and B Chairperson: Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia Chairperson: Anna Roberts, Australasian Society for HIV Medicine, Australia | Cross-Track Symposium - Hepatitis and Liver Cancer Ellery Room A and D Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Prof. Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory, CEVHAP, Australia | ||
| 2.00pm - 2.10pm Introduction and overview: why are human rights, the law and discrimination important in viral hepatitis MacDonnel Room A and B Annie Madden, Executive Officer , Australian Injecting & Illicit Drug Users League (AIVL), Australia | 2.00pm - 2.15pm How does hepatitis cause liver cancer? Ellery Room A and D Dr Nadia Warner, Virologist and Principal Investigator , Victorian Infectious Diseases Reference Laboratory, Australia | ||
| 2.10pm - 2.25pm Vignette 1 – Prevention of viral hepatitis within prisons MacDonnel Room A and B Dr Helen Watchirs, ACT Human Rights Commissioner, Australia | 2.15pm - 2.30pm Novel diagnostics in viral hepatitis – how can they address the liver cancer burden? Ellery Room A and D Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia | ||
| 2.25pm - 2.40pm Vignette 2 – Australia’s role in country of origin for hepatitis B MacDonnel Room A and B Nafisa Yussf, Community Development Officer, Centre for Culture, Ethnicity and Health Australia | 2.30pm - 2.45pm Liver cancer in the Northern Territory – recent data and how it can guide diagnosis and management Ellery Room A and D Dr Josh Davis, Diseases physician , John Hunter Hopsital, Australia | ||
| 2.40pm - 2.55pm Vignette 3 – Workplace discrimination MacDonnel Room A and B Bridget Akers | 2.45pm - 3.00pm The National Liver Cancer Prevention Policy and future policy directions for Australian Cancer Councils Ellery Room A and D Monica Robotin, Chief Investigator of the B Positive program, Australia | ||
| 2.55pm - 3.10pm Vignette 4 – The future of hepatitis C treatment MacDonnel Room A and B Helen Tyrell, CEO, Hepatitis Australia | 3.00pm - 3.25pm Panel Discussion Ellery Room A and D Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Dr Josh Davis, Diseases physician , John Hunter Hopsital, Australia Prof. Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory, CEVHAP, Australia Dr Nadia Warner, Virologist and Principal Investigator , Victorian Infectious Diseases Reference Laboratory, Australia | ||
| 3:10 pm - 3:30 pm | Panel Discussion MacDonnel Room A and B Annie Madden, Executive Officer , Australian Injecting & Illicit Drug Users League (AIVL), Australia Dr Helen Watchirs, ACT Human Rights Commissioner, Australia Nafisa Yussf, Community Development Officer, Centre for Culture, Ethnicity and Health Australia Helen Tyrell, CEO, Hepatitis Australia Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia Anna Roberts, Australasian Society for HIV Medicine, Australia | 3.25pm - 3.30pm Launch - Liver cancer resource for people aff ected by primary liver cancer in four languages Ellery Room A and D Monica Robotin, Chief Investigator of the B Positive program, Australia | ||
| 3:30 pm - 4:00 pm | Afternoon Tea in Exhibition & Poster Viewing Area MacDonnel C | |||
| 4:00 pm - 5:30 pm | Symposia Session 1: Epi, PH & Prevention - Cascade of Care (Access to care) MacDonnel Room A and B Mark Stoove, Head of the HIV Research and Justice Health Research Programs, Burnet Institute in Melbourne, Australia Vanessa Towell, viral hepatitis program manager , National Policy and Education Division at ASHM, Australia | Symposia Session 2: Clinical Care - AHA Nursing Session Ellery Room A and D Chairperson: Eleanor Hooke, Clinical Nurse Consultant, Department of Health, Australia Chairperson: Megan Phelps, Clinical Practice Consultant - Research – Hepatology, Royal Adelaide Hospital, Australia | Symposia Session 3: Community & Social Research - Connecting to Care Workshop Ellery B Chairperson: Helen Tyrell, CEO, Hepatitis Australia Chairperson: Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | Symposia Session 4: Basic Science - HCV1 - Curing HCV: What will the virus try next? Ellery C Chairperson: Tanya Applegate, Molecular Virologist and Senior Lecturer , Kirby Institute at the University of New South Wales in Sydney, Australia Chairperson: Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia |
| 4.00pm - 4.20pm The cascade of care for people living with chronic hepatitis B: access to treatment and monitoring in Australia. MacDonnel Room A and B Dr Nicole Allard, General Practitioner , Joslin Clinic, Cohealth in West Footscray, Melbourne, Australia | 4.00pm - 4.25pm Successes and challenges of delivering hepatits C nursing care in the Top End Ellery Room A and D Rebecca Katiforis, Clinical Nurse Consultant, Royal Darwin Hospital’s Viral Hepatitis Clinic | 4.00pm - 4.05pm Chronic Hepatitis Primary Care Pathway Ellery B Judith Bevan, Senior Policy and Planning Officer, Sexual Health and Blood-borne Virus Program, Communicable Disease Control Directorate, Department of Health, Western Australia. | 4.00pm - 4.15pm Genetic determinants of HCV treatment outcome Ellery C Alex Thompson, Research Fellow , University of Melbourne (St Vincent's Hospital Melbourne), Australia |
| 4.20pm - 4.40pm The HCV Care Cascade: Mapping the HCV clinical care pathway in Australia MacDonnel Room A and B Jason Grebely, Epidemiologist and Senior Lecturer in the Viral Hepatitis , Kirby Institute, UNSW, Australia | 4.25pm - 4.50pm From Treatment to Peer Worker MacDonnel Room A and B Frances Tenison, CNC, A W Morrow Gastro and Liver Centre Damian House, Hepatitis Peer Educator/Aboriginal HEO , Sydney Local Health District, Australia | 4.05pm - 4.10pm Livermates Ellery B Nicky Bath, CEO, NSW South Wales Users and AIDS Association, Australia | 4.15pm - 4.30pm QUAC: Q80K mUtation prevalence in an Australian hepatitis C population. Ellery C Dr Adrian Teck Leng Ong, Staff Specialist at Blacktown Hospital and PhD candidate at the Storr Liver Centre, Westmead Millennium Institute, Australia |
| 4.40pm - 4.50pm Cascade of care for Aboriginal and Torres Strait Islander people MacDonnel Room A and B Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia | 4.10pm - 4.15pm B Positive Program Ellery B Monica Robotin, Chief Investigator of the B Positive program, Australia | 4.30pm - 4.45pm Hepatitis C virus can accumulate mutations that confer resistance to a novel broadly neutralizing antibody MAb24 Ellery C Jun Gu, PhD student in the Viral Fusion Laboratory , Burnet Institute, Australia | |
| 4.50pm - 5.00pm Cultural lenses – Pathways to care from prevention to treatment MacDonnel Room A and B Enaam Oudih, Manager, PEACE Multicultural Services, Relationships Australia | 4.50pm - 5.05pm Hepatology Nursing in the Era of Expanding Hepatitis C Evidence Ellery Room A and D Jacqui Richmond, Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia | 4.15pm - 4.20pm Indigenous hepatitis B App Ellery B Dr Josh Davis, Diseases physician , John Hunter Hopsital, Australia Dr Jane Davies, Clinical Fellow , Royal Darwin Hospital, Australia | 4.45pm - 5.00pm Preclinical development of a prophylactic vaccine for Hepatitis C virus using a novel E2 core domain. Ellery C Heidi Drummer, Co-Head of the Viral Fusion Laboratory, Burnet Institute, Melbourne, Australia |
| 5:00 pm - 5:15 pm | 5.00pm - 5.10pm A trickle not a cascade - caring for people who inject drugs MacDonnel Room A and B Jude Byrne, Senior Project Worker, Australian Injecting & Illicit Drug, ACT, Australia | 5.05pm - 5.30pm Hepatitis C in SA from Tertiary to Primary Care Ellery Room A and D Rosalie Altus, Clinical Practice Consultant Viral Hepatitis Liaison Nurse, Australia | 4.20pm - 4.40pm Breakout 1 - Hep B Ellery B | 5.00pm - 5.15pm Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C Ellery C Associate Professor Silvana Gaudieri, Leads Research Teams , School of Anatomy, Physiology and Human Biology , The University of Western Australia and Institute for Immunology and Infectious Diseases, Murdoch University, Australia |
| 5.10pm - 5.30pm Panel Discussion MacDonnel Room A and B Jude Byrne, Senior Project Worker, Australian Injecting & Illicit Drug, ACT, Australia Jason Grebely, Epidemiologist and Senior Lecturer in the Viral Hepatitis , Kirby Institute, UNSW, Australia Enaam Oudih, Manager, PEACE Multicultural Services, Relationships Australia Mark Stoove, Head of the HIV Research and Justice Health Research Programs, Burnet Institute in Melbourne, Australia Vanessa Towell, viral hepatitis program manager , National Policy and Education Division at ASHM, Australia Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Dr Nadia Warner, Virologist and Principal Investigator , Victorian Infectious Diseases Reference Laboratory, Australia | 4.40pm - 5.00pm Breakout 2 - Hep C Ellery B | 5.15pm - 5.30pm Cytolytic DNA vaccines enhance immunity to hepatitis C virus. Ellery C Eric Gowans, NHMRC Senior Research Fellow, Australia | |
| 5.00pm - 5.30pm Discussion Ellery B | |||
| 5:30 pm - 5:45 pm | Transfers to Conference Dinner, The Quarry Outside Ghan Foyer | |||
| 6:00 pm - 10:00 pm | Conference Dinner, The Quarry Outback Quarry | |||
| 19/09/2014 | ||||
| 6:30 am | Registration Ghan Foyer | |||
| 7:00 am - 8:50 am | Satellite Session - ALA Symposium sponsored by BMS MacDonnel C Chairperson: Associate Professor Amany Zekry, St George's Hospital Sydney, Australia | |||
| 7:00 am - 7:20 am | Breakfast Served MacDonnel C | |||
| 7:20 am - 7:30 am | Welcome and Introductions MacDonnel C Associate Professor Amany Zekry, St George's Hospital Sydney, Australia | |||
| 7:30 am - 7:50 am | Stratifying risk of liver diseases progression in HCV cirrhosis MacDonnel C Associate Professor Amany Zekry, St George's Hospital Sydney, Australia | |||
| 7:50 am - 8:10 am | HCC burden- ongoing screening in cirrhotics who clear the virus MacDonnel C Associate Professor Simone Strasser, Royal Prince Alfred Hospital, Sydney, Australia | |||
| 8:10 am - 8:30 am | The impact of DAA on the burden of HCV related liver cirrhosis MacDonnel C Stuart Roberts | |||
| 8:30 am - 8:45 am | Panel Discussion MacDonnel C Associate Professor Amany Zekry, St George's Hospital Sydney, Australia Associate Professor Simone Strasser, Royal Prince Alfred Hospital, Sydney, Australia Stuart Roberts | |||
| 8:45 am - 8:50 am | Closing remarks and thanks MacDonnel C Associate Professor Amany Zekry, St George's Hospital Sydney, Australia | |||
| 8:50 am - 9:00 am | Movement to next concurrent sessions No location | |||
| 9:00 am - 10:30 am | Symposia Session: Clinical Care - New challenges in the management of hepatitis C in the DAA era MacDonnel Room A and B Chairperson: Dr Josh Davis, Diseases physician , John Hunter Hopsital, Australia Chairperson: Associate Professor Amany Zekry, St George's Hospital Sydney, Australia | Symposia Session : Epi, PH & Prevention - Approaches to hepatitis B and hepatitis C prevention in rural & regional settings Ellery Room A and D Chairperson: Lisa Maher Chairperson: Mark Stoove, Head of the HIV Research and Justice Health Research Programs, Burnet Institute in Melbourne, Australia | Symposia Session: Community & Social Research - Working with CALD communities in Viral Hepatitis Ellery B Chairperson: Zhihong Gu, Ethnic Communities Council of Queensland, Australia Chairperson: Alison Coelho, Manager of Multicultural Health and Support Service, Center for Culture, Ethnicity and Health, Melbourne, Australia | Symposia Session: Basic Science - HBV 1: Chronic HBV infection: factors infl uencing disease progression Ellery C Chairperson: Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia Chairperson: Eric Gowans, NHMRC Senior Research Fellow, Australia |
| 9.00am - 9.30am Hepatitis C genotype 3 infection – Is it the new Genotype 1? MacDonnel Room A and B Professor Maggie Bassendine, Clinician Scientist, Visiting Professor at Imperial College, London and Emeritus Professor at Newcastle University, UK | 9.00am - 9.10am NSP in urban, rural and regional settings – distribution models and viral hepatitis prevention coverage Ellery Room A and D Dr Jenny Iversen, Lecturer, Kirby Institute, Australia | 9.00am - 9.15am Strengthening Community Responses to Hepatitis B Ellery B Roslyn Le, Research Fellow , Australian Research Centre in Sex, Health and Society at La Trobe University, Australia William Mude, PhD candidate , Australian Research Centre in Sex, Health and Society at La Trobe University, Australia | 9.00am - 9.30am Model + host molecular eff ectors of HBV control Ellery C Dr Marc Pellegrini, Laboratory Head, Infection and Immunity Division, Walter and Eliza Hall Institute of Medical Research and Honorary Senior Fellow, Faculty of Medicine, Dentistry and Health Sciences University of Melbourne., Walter and Eliza Hall Institute, Australia |
| 9.10am - 9.20am Providing OST in rural/regional settings – what are the opportunities to enhance viral hepatitis prevention and care MacDonnel Room A and B Conjoint Associate P Adrian Dunlop, University of Newcastle, Australia | 9.15am - 9.30am No vaccination against discrimination: Chinese Viral Hepatitis Needs Assessment. Ellery B Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Melbourne, Australia | ||
| 9.30am - 10.00am Treating hepatitis C patients with advanced liver disease and post liver transplantation in the DAA era MacDonnel Room A and B Associate Professor Simone Strasser, Royal Prince Alfred Hospital, Sydney, Australia | 9.20am - 9.35am Integrated viral hepatitis primary care models in rural and regional settings – Insights from the Kirketon Road Centre Ellery Room A and D Symposia Speaker: Dr Phillip Read, Sexual Health Physician, Staff Specialist and Manager , Kirketon Road Centre, Australia | 9.30am - 9.45am Tradition and Innovation Working Hand in Hand: Engaging Communities Affected by Chronic Hepatitis B Ellery B Marina Suarez, Health Promotion Officer, Multicultural HIV and Hepatitis, Australia | 9.30am - 10.00am Novel therapeutic that kills HBV infected cells Ellery C Dr Marc Pellegrini, Laboratory Head, Infection and Immunity Division, Walter and Eliza Hall Institute of Medical Research and Honorary Senior Fellow, Faculty of Medicine, Dentistry and Health Sciences University of Melbourne., Walter and Eliza Hall Institute, Australia |
| 9.35am - 9.50am BBV prevention in Aboriginal communities: the perspectives of Aboriginal PWID from the RISE Project Ellery Room A and D Nicky Bath, CEO, NSW South Wales Users and AIDS Association, Australia | 9.45am - 10.00am Know Your Hepatitis B Status (with African communities) Ellery B Sharna Ciotti | ||
| 10.00am - 10.30am Expanding access to hepatitis C treatment through primary care: challenges and opportunities MacDonnel Room A and B Professor Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia | 9.50am - 10.05am Promoting or preventing harm?: integrating viral hepatitis prevention in Aboriginal Community Controlled Health Organisation services Ellery Room A and D Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia | 10.00am - 10.15am Chronic Hepatitis B Education in the North Queensland Hmong Community: Positive Change through Process and Perseverance Ellery B Yvonne Drazic, Australia | 10.00am - 10.15am Spliced HBV genomes and truncated surface proteins are associated with ground glass hepatocytes, the neoplastic precursors to HBV associated hepatocellular carcinoma Ellery C Dr Nadia Warner, Virologist and Principal Investigator , Victorian Infectious Diseases Reference Laboratory, Australia |
| 10.05am - 10.30am Facilitated panel discussion with presenters Ellery Room A and D Conjoint Associate P Adrian Dunlop, University of Newcastle, Australia Dr Jenny Iversen, Lecturer, Kirby Institute, Australia Lisa Maher Dr Phillip Read, Sexual Health Physician, Staff Specialist and Manager , Kirketon Road Centre, Australia Mark Stoove, Head of the HIV Research and Justice Health Research Programs, Burnet Institute in Melbourne, Australia Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia | 10.15am - 10.30am Discussion Ellery B | 10.15am - 10.30am Prevalence and Molecular Virology of Hepatitis Delta Virus in the Western Pacific Region Ellery C Margaret Littlejohn, Molecular Virologist and Senior Medical Scientist , Molecular Research and Development laboratory at VIDRL, Australia | |
| 10:30 am - 11:00 am | Morning Tea in Exhibition and Poster Area MacDonnel C | |||
| 11:00 am - 12:30 pm | Proffered Paper Session: Epi, PH & Prevention - Prevention and Care programs MacDonnel Room A and B Chairperson: Tracey Hutt Chairperson: Annie Balcomb | Proffered Paper Session: Clinical Care - HCV Ellery Room A and D Chairperson: Dr Jane Davies, Clinical Fellow , Royal Darwin Hospital, Australia Chairperson: Sushena Krishnaswamy, Alice Springs Hospital, Australia | Proffered Paper Session: Community & Social Research - Living with Viral Hepatitis Ellery B Chairperson: Annie Madden, Executive Officer , Australian Injecting & Illicit Drug Users League (AIVL), Australia Chairperson: Jake Rance, Research Associate, Centre for Social Research, Australia | Proffered Paper Session: Basic Science -HBV 2: The HBV journey: Virus entry to viral variants Ellery C Chairperson: Heidi Drummer, Co-Head of the Viral Fusion Laboratory, Burnet Institute, Melbourne, Australia Chairperson: Professor Margaret Hellard, Head of the Centre for Population Health and Head of Hepatitis Services Infectious Diseases Unit, , Burnet Institute in Melbourne and The Alfred Hospital, Melbourne, Australia |
| 11.00am - 11.15am Trends of hepatitis B surface antigen carriage in central Nepal: a reality check from a mass screening after nationwide HBV vaccination MacDonnel Room A and B Dhruba Acharya, Lecturer/Immunologist, Kathmandu University School of Medical School, Nepal | 11.00am - 11.15am Factors Associated with Hepatitis C Virus Rna Levels in Early Acute and Early Chronic Infection: The Inc3 Study Ellery Room A and D Behzad Hajarizadeh, PhD student, The Kirby institute, Australia | 11.00am - 11.15am Psychosocial Health among People with Chronic Hepatitis B in Australia Ellery B Jacqui Richmond, Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia | 11.00am - 11.30am Bile acids and hepatitis B virus compete for the Na+-dependent taurocholate cotransporting polypeptide (NTCP) Ellery C Dr Dieter Glebe, Head, National Reference Centre for Hepatitis B and D Viruses, Institute of Medical Virology, Germany |
| 11.15am - 11.30am Estimating uptake of treatment for chronic hepatitis B infection across Australia MacDonnel Room A and B Jennifer MacLachlan, Epidemiologist, Victorian Infectious Diseases Reference Laboratory, Australia | 11.15am - 11.30am Effect of Treatment Willingness on Specialist Assessment and Treatment Uptake for Hepatitis C Virus Infection among People Who Use Drugs: The Ethos Study Ellery Room A and D Maryam Alavi, Epidemiologist and a Research Associate , The Kirby Institute, Australia | 11.15am - 11.30am Experiences of ageing and living with hepatitis C: Reflections from a cohort of people who inject drugs Ellery B Peter Higgs, Curtin Research Fellow , National Drug Research Institute in Melbourne, Australia | |
| 11.30am - 11.45am Evaluation of New South Wales Hepatitis B Prescriber Program – Challenges and Succeses MacDonnel Room A and B Vanessa Towell, viral hepatitis program manager , National Policy and Education Division at ASHM, Australia | 11.30am - 11.45am Regression of advanced fibrosis following virological response to anti-HCV therapy Ellery Room A and D Marianne Martinello, Viral Hepatitis Fellow , St Vincent’s Hospital, Sydney, Australia | 11.30am - 11.45am Hepatitis C and Ageing: Perspectives from the Clinical, Comuunity and Government Sectors Ellery B Jacqui Richmond, Research Fellow , Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia | 11.30am - 11.45am The role of genotype in HBV replication and natural history. Ellery C Peter Revill, Senior Medical Scientist, Victorian Infectious Diseases Reference Laboratory, Australia |
| 11.45am - 12.00pm Characteristics of chronic hepatitis B infection in SW Sydney: clinical correlates and policy implications MacDonnel Room A and B Monica Robotin, Chief Investigator of the B Positive program, Australia | 11.45am - 12.00pm Efficacy and Safety of Daclatasvir in Combination with Asunaprevir (Dcv+Asv) in Cirrhotic and Non-Cirrhotic Patients with Hcv Genotype 1b: Results of the Hallmark Dual Study Ellery Room A and D Stuart Roberts | 11.45am - 12.00pm Yarning about Hep C; Aboriginal Victorians telling our stories about living with Hep C Ellery B Andrew Bamblett Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia | 11.45am - 12.00pm Hepatitis B Virus in African immigrants living in Australia. Ellery C Rosalind Edwards, Medical Scientist , Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia |
| 12.00pm - 12.15pm Champions and challenges in Australia’s response to Blood Borne Viruses MacDonnel Room A and B Kevin Marriott, Policy and Advocacy Officer, Australia | 12.00pm - 12.15pm Treating hepatitis C: Does gender matter? Ellery Room A and D Anna Olsen, NHMRC post-doctoral fellow , Kirby Institute, UNSW, Australia | 12.00pm - 12.15pm Your Mob, My Mob, Our Mob (YMMMOM) Peer Education Project Ellery B Kerry Walker, Aboriginal Project Officer - Education and Development , Hepatitis NSW | 12.00pm - 12.15pm Directly Cytopathic Drug Resistant HBV Strains Ellery C Danni Colledge |
| 12.15pm - 12.30pm - Discussion MacDonnel Room A and B | 12.15pm - 12.30pm - Discussion Ellery Room A and D | 12.15pm - 12.30pm - Discussion Ellery B | 12.15pm - 12.30pm Use of Biomarkers to Monitor HBV Therapy Ellery C Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia |
| 12:30 pm - 1:30 pm | Lunch in Exhibition and Poster Area MacDonnel C | |||
| 1:30 pm - 3:00 pm | Proffered Paper Session: Epi, PH & Prevention - Priority Populations MacDonnel Room A and B Chairperson: Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Chairperson: Steven Tong | Proffered Paper Session: Clinical Care - Non-tertiary sites and models of care for HCV Ellery Room A and D Chairperson: Suresh Sharma, Clinical Nurse Consultant- Liver Clinic, Royal Darwin Hospital- Top End Health Service, Australia Chairperson: Stuart Roberts | Proffered Paper Session: Community & Social Research - Facilitating access to treatment Ellery B Chairperson: Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia Chairperson: Jack Wallace, Research Fellow, Australian Research Centre in Sex, Health and Society, Melbourne, Australia | Proffered Paper Session: Basic Science - HCV 2 : Molecular and social networks: informing HCV treatment Ellery C Chairperson: Associate Professor Silvana Gaudieri, Leads Research Teams , School of Anatomy, Physiology and Human Biology , The University of Western Australia and Institute for Immunology and Infectious Diseases, Murdoch University, Australia Chairperson: Mark Douglas, Senior Lecturer, University of Sydney, Australia |
| 1.30pm - 1.45pm Hepatitis B Knowledge among People with Chronic Hepatitis B in Australia MacDonnel Room A and B Behzad Hajarizadeh, PhD student, The Kirby institute, Australia | 1.30pm - 1.45pm Trends in Health Services Utilization Attributable to Hepatocellular Carcinoma: A Population-Based Cohort Study Ellery Room A and D Hla-Hla (Rosie) Thein, Canada | 1.30pm - 1.45pm Psychosocial Factors Influencing Successful Interferon-Based Hepatitis C Treatment Outcomes Ellery B Victoria Sublette, PhD candidate , University of Sydney, Australia | 1.30pm - 2.00pm Hepatitis C treatment as prevention in people who inject drugs – what is the role of the injecting network? Ellery C Professor Margaret Hellard, Head of the Centre for Population Health and Head of Hepatitis Services Infectious Diseases Unit, , Burnet Institute in Melbourne and The Alfred Hospital, Melbourne, Australia |
| 1.45pm - 1.53pm Automatic Dispensing Machines: No Evidence of a Honey-Pot Effect MacDonnel Room A and B Bethany White, Associate Lecturer, Sydney Medical School’s Discipline of Addiction Medicine, University of Sydney, Australia | 1.45pm - 2.00pm Pilot for a community-based assessment and support programme for hepatitis C in New Zealand Ellery Room A and D John Hornell, Chief Executive Officer, Hepatitis Foundation of New Zealand | 1.45pm - 2.00pm Fibroscan Testing as a Community Engagement Strategy Ellery B Erin Devine, HIV and Related Programs Health Promotion Officer , Sydney Local Health District, Australia | |
| 1.53pm - 2.01pm Increasing the Victorian ACCHO response to injecting drugs and hepatitis c prevention MacDonnel Room A and B Peter Waples-Crowe, Victorian Aboriginal Community Controlled Health Organisation, Australia | 2.00pm - 2.15pm No prejudice! Being a prisoner, indigenous or having a psychiatric illness should not limit access to treatment for chronic hepatitis c infection. Ellery Room A and D James Elliott, Final Year Medical Student , University of Queensland, Australia | 2.00pm - 2.15pm Evaluation of “The hepatitis B story” – an educational resource to use in discussion with people who have low health literacy Ellery B Gabrielle Bennett, Victorian Viral Hepatitis Educator, St Vincent’s Hospital, Australia | |
| 2.01pm - 2.09pm The impact of overseas hepatitis B vaccination programs on the future burden of hepatitis B in Australia MacDonnel Room A and B Zoe Stephens, Undergraduate Student, RMIT University, Australia | 2.15pm - 2.30pm Looking Beyond the Bars – The first hepatitis C treatment program in Qld for women in custody Ellery B Jodie Walton, Educator, Hepatitis Queensland, Australia | 2.00pm - 2.15pm Phylogenetic clustering of Hepatitis C among street-involved youth in Vancouver, Canada Ellery C Evan Cunningham, PhD Student , University of New South Wales, Australia | |
| 2.09pm - 2.24pm Incident hepatitis B infection and immunisation uptake in Australian prison inmates MacDonnel Room A and B Luke McCredie, Research Nurse, Justice Health NSW, Australia | 2.15pm - 2.30pm What makes a community-based HCV treatment program acceptable to clients? Insights from health care providers and clients Ellery Room A and D Julie Mooney-Somers | 2.30pm - 2.45pm Discussion Ellery B | 2.15pm - 2.30pm Molecular epidemiology of hepatitis C virus infections among people who inject drugs in Vancouver, Canada Ellery C Brendan Jacka, PhD candidate , Kirby Institute, UNSW, Australia |
| 2.24pm - 2.39pm Can Primary Health Care Identify the Diverse Population Living with Chronic Hepatitis B? MacDonnel Room A and B Professor Margaret Hellard, Head of the Centre for Population Health and Head of Hepatitis Services Infectious Diseases Unit, , Burnet Institute in Melbourne and The Alfred Hospital, Melbourne, Australia | 2.30pm - 2.45pm Treating Hepatitis C in Primary Care: Results from a Pilot Program Ellery Room A and D David Baker, Senior Lecturer , University of Notre Dame, Australia | 2.30pm - 2.45pm Factors associated with phylogenetic clustering of acute hepatitis C virus infection in Australia Ellery C Tanya Applegate, Molecular Virologist and Senior Lecturer , Kirby Institute at the University of New South Wales in Sydney, Australia | |
| 2.39pm - 3.00pm Discussion MacDonnel Room A and B | 2.45pm - 3.00pm Discussion Ellery Room A and D | 2.45pm - 3.00pm Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study Ellery C Behzad Hajarizadeh, PhD student, The Kirby institute, Australia | |
| 3:00 pm - 3:30 pm | Afternoon Tea in Exhibition and Poster Area MacDonnel C | |||
| 3:30 pm - 5:00 pm | Closing Plenary 4 - Eradication of hepatitis debates MacDonnel Room A and B Chairperson: Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia Chairperson: Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | |||
| 3:30pm - 4:10 pm | Debate - Hepatitis C vaccine development is still required in the era of vastly improved treatment MacDonnel Room A and B Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia Dr John Ward, Director of the Division of Viral Hepatitis , Centers for Disease Control and Prevention (CDC), USA Helen Tyrell, CEO, Hepatitis Australia Professor Kimberly Page, University of New Mexico Health Sciences Center, USA Associate Professor James Ward, Deputy Program Head, Baker IDI, Australia Charles Henderson, NZ Needle Exchange Program, New Zealand Professor Greg Dore, Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW, Australia | |||
| 4:10 pm - 4:50 pm | Debate - Despite the availability of effective treatments and vaccination for hepatitis B, we should prioritise funding for research to find a cure MacDonnel Room A and B Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia Dr Dieter Glebe, Head, National Reference Centre for Hepatitis B and D Viruses, Institute of Medical Virology, Germany Melanie Eagle, Chief Executive Officer , Hepatitis Victoria, Australia Professor Maggie Bassendine, Clinician Scientist, Visiting Professor at Imperial College, London and Emeritus Professor at Newcastle University, UK Dr Benjamin Cowie, Epidemiologist and Physician, Epidemiology Unit VIDRL, Doherty Institute, Melbourne, Australia Yvonne Drazic, Australia Dr Jill Benson, GP, Kakarrara Wilurrara Health Alliance, Australia | |||
| 4:50 pm - 5:00 pm | Wrap Up MacDonnel Room A and B Scott Bowden, Head of the Molecular Microbiology Laboratory, Australia, Victorian Infectious Diseases Reference Laboratory, Australia Professor Carla Treloar, Deputy Director and Head of the Hepatitis Research Group, Centre for Social Research at UNSW, Australia | |||
| 5:00 pm - 5:00 pm | Conference Close MacDonnel Room A and B | |||
| 5:30 pm - 8:00 pm | Informal BBQ Lasseters Hotel Pool Area | |||
